{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:57:08Z","timestamp":1790546228259,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2022D01C310"],"award-info":[{"award-number":["2022D01C310"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37213","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T03:10:03Z","timestamp":1724987403000},"page":"e37213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A pan-cancer analysis of the association of METRN with prognosis and immune infiltration in human tumors"],"prefix":"10.1016","volume":"10","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9482-7716","authenticated-orcid":false,"given":"Guofu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e37213_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.heliyon.2024.e37213_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.21147\/j.issn.1000-9604.2020.02.01","volume":"32","author":"Sun","year":"2020","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e37213_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chinese Med J"},{"key":"10.1016\/j.heliyon.2024.e37213_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccell.2020.05.021","article-title":"Pan-cancer early detection: hype or hope?","volume":"38","author":"Srivastava","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.heliyon.2024.e37213_bib5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/sj.emboj.7600202","article-title":"Meteorin: a secreted protein that regulates glial cell differentiation and promotes axonal extension","volume":"23","author":"Nishino","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.heliyon.2024.e37213_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12031-009-9189-4","article-title":"Characterization of meteorin\u2014an evolutionary conserved neurotrophic factor","volume":"39","author":"J\u00f8rgensen","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e37213_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fncel.2016.00177","article-title":"Over-expression of meteorin drives gliogenesis following striatal injury","volume":"10","author":"Wright","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e37213_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/jcbfm.2011.156","article-title":"Meteorin is a chemokinetic factor in neuroblast migration and promotes stroke-induced striatal neurogenesis","volume":"32","author":"Wang","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.heliyon.2024.e37213_bib9","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1242\/jcs.063784","article-title":"Meteorin promotes the formation of GFAP-positive glia via activation of the Jak-STAT3 pathway","volume":"123","author":"Lee","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.heliyon.2024.e37213_bib10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.expneurol.2012.06.027","article-title":"Meteorin reverses hypersensitivity in rat models of neuropathic pain","volume":"237","author":"J\u00f8rgensen","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.heliyon.2024.e37213_bib11","first-page":"225","article-title":"Encapsulated cell-based biodelivery of meteorin is neuroprotective in the quinolinic acid rat model of neurodegenerative disease","volume":"30","author":"Torn\u00f8e","year":"2012","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e37213_bib12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/j.pain.0000000000001569","article-title":"Antihyperalgesic effects of Meteorin in the rat chronic constriction injury model: a replication study","volume":"160","author":"Xie","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.heliyon.2024.e37213_bib13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpain.2022.10.015","article-title":"Meteorin alleviates paclitaxel-induced peripheral neuropathic pain in mice","volume":"24","author":"Sankaranarayanan","year":"2023","journal-title":"J. Pain"},{"key":"10.1016\/j.heliyon.2024.e37213_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41571-021-00492-2","article-title":"Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm","volume":"18","author":"Nakamura","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e37213_bib15","article-title":"Potential diagnostic and therapeutic roles of exosomes in pancreatic cancer","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.heliyon.2024.e37213_bib16","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3892\/mmr.2015.3610","article-title":"Meteorin is upregulated in reactive astrocytes and functions as a negative feedback effector in reactive gliosis","volume":"12","author":"Lee","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.heliyon.2024.e37213_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/glia.20600","article-title":"Meteorin regulates angiogenesis at the gliovascular interface","volume":"56","author":"Park","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.heliyon.2024.e37213_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131013","article-title":"Maternal serum meteorin levels and the risk of preeclampsia","volume":"10","author":"Garc\u00e9s","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e37213_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ajem.2020.11.022","article-title":"The effect of diclofenac sodium intoxication on the cardiovascular system in rats","volume":"46","author":"Dolanbay","year":"2021","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.heliyon.2024.e37213_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111361","article-title":"Meteorin links the bone marrow hypoxic state to hematopoietic stem\/progenitor cell mobilization","volume":"40","author":"Dai","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.heliyon.2024.e37213_bib21","article-title":"Meteorin regulates mesendoderm development by enhancing nodal expression","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e37213_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1102","article-title":"Over expression of METRN predicts poor clinical prognosis in colorectal cancer","volume":"8","author":"Xu","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.heliyon.2024.e37213_bib23","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/jcm10132973","article-title":"Meteorin is a novel therapeutic target for wet age-related macular degeneration","volume":"10","author":"Delaunay","year":"2021","journal-title":"JCM"},{"key":"10.1016\/j.heliyon.2024.e37213_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/biology9110385","article-title":"Cytoskeletal remodeling in cancer","volume":"9","author":"Aseervatham","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.heliyon.2024.e37213_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118816119","article-title":"LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation","volume":"119","author":"Kremer","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.heliyon.2024.e37213_bib26","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1021\/acs.jmedchem.3c00011","article-title":"X-Ray crystal structure-guided discovery of novel indole analogues as colchicine-binding site tubulin inhibitors with immune-potentiating and antitumor effects against melanoma","volume":"66","author":"Ren","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e37213_bib27","doi-asserted-by":"crossref","first-page":"25101","DOI":"10.18632\/aging.104084","article-title":"Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker","volume":"12","author":"Bai","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.heliyon.2024.e37213_bib28","article-title":"Functional and clinical characteristics of cell adhesion molecule CADM1 in cancer","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.heliyon.2024.e37213_bib29","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3390\/cells11142235","article-title":"Integrin signaling shaping BTK-inhibitor resistance","volume":"11","author":"Polcik","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e37213_bib30","article-title":"EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis","author":"Wang","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e37213_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12079-022-00687-x","article-title":"METTL13 facilitates cell growth and metastasis in gastric cancer via an eEF1A\/HN1L positive feedback circuit","volume":"17","author":"Wu","year":"2023","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.heliyon.2024.e37213_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000533610","article-title":"Chronic lymphocytic leukemia: disease biology","volume":"147","author":"Koehrer","year":"2024","journal-title":"Acta Haematol."},{"key":"10.1016\/j.heliyon.2024.e37213_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157665","article-title":"B cell receptor signaling strength modulates cancer immunity","volume":"132","author":"Ye","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e37213_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37213_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2019.08.002","article-title":"Cancer and the immune system: the history and background of immunotherapy","volume":"35","author":"Abbott","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.heliyon.2024.e37213_bib36","first-page":"2295","article-title":"Phase II randomized study of ramucirumab and pembrolizumab versus standard of care in advanced non\u2013small-cell lung cancer previously treated with immunotherapy\u2014lung-MAP S1800A","volume":"40","author":"Reckamp","year":"2022","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.heliyon.2024.e37213_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-023-01800-3","article-title":"Co-Inhibition of TIGIT and PD-1\/PD-L1 in cancer immunotherapy: mechanisms and clinical trials","volume":"22","author":"Chu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2024.e37213_bib38","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jama.2021.12836","article-title":"Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st randomized clinical trial","volume":"326","author":"Luo","year":"2021","journal-title":"JAMA"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024132446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024132446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:11:33Z","timestamp":1790543493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024132446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024132446"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37213","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pan-cancer analysis of the association of METRN with prognosis and immune infiltration in human tumors","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37213"}}